To come to this finding, researchers tracked CLABSIs for one year at a 1,200 bed hospital center. They monitored 209 ICU beds and flagged patients moved to the ICU for a CLABSI contracted in a non-ICU setting.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Of 136 patients and 156 CLABSIs:
- 57 patients were treated for hematological malignancy.
- The device utilization ratio — number of catheter days divided by number of patient days — was 0.27.
- 76 percent of CLABSIs occurred with a tunneled line.
- 21 percent of CLABSIs occurred with a peripherally inserted central catheter.
- Total mortality was 23 percent.
In addition, researchers noted CLABSI rates were significantly higher in non-ICU settings and were associated with significant mortality, with patients treated for HM having the highest mortality.
More Articles on Infection Control & Clinical Quality:
AAMC Releases Guide to Evaluating Public Report Card Quality
